Your session is about to expire
← Back to Search
CFD Simulations for Pediatric Sleep Apnea (OSA-MRI Trial)
OSA-MRI Trial Summary
This trial is testing a new tool to predict surgical outcomes for pediatric patients with obstructive sleep apnea (OSA). The goal is to improve the success rates of surgeries by using computational fluid dynamics (CFD) simulations of respiratory airflow in the upper airways.
OSA-MRI Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowOSA-MRI Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.OSA-MRI Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I may have a blocked airway due to issues like a large tongue or small jaw.My child cannot have sedatives due to health reasons.I am between 5 and 18 years old.My parents chose surgery for me without trying CPAP first.I am either male or female.You have tried using CPAP machine before, but it did not work for you.I have tried CPAP therapy without success.I am between 3 and 18 years old.My child is successfully treated with CPAP.I still have severe sleep apnea after surgery, with an oAHI > 5.My child has braces or metal rods.I need surgery for sleep apnea as advised by my surgeon.I may have a blockage in my upper airway due to conditions like a large tongue or small jaw.
- Group 1: Phase 1 - Contrast 129Xe MRI ages 5-18
- Group 2: Phase 2 - Contrast 129Xe MRI ages 3-18
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To what extent is this clinical trial being populated with participants?
"Affirmative. As evidenced on the clinicaltrials.gov website, 120 patients are being recruited at this time for a trial that was initially posted in August of 2019 and modified as recently as July 2021."
What type of individuals are eligible to participate in this scientific research?
"This medical trial is recruiting 120 minors with apnea, ranging in age from 3 to 18. In order for a child to be enrolled, they must have persistent moderate or severe OSA after adenotonsillectomy; an oAHI > 5 per hour of sleep.; clinical indication or suspicion of upper-airway obstruction such as hypertrophy of the lingual tonsils or micrognathia; and parents who elect surgery without CPAP intervention. Both males and females are accepted for this study's aims 2 & 3."
Does the protocol for this experiment include participants who have attained majority?
"This clinical trial is looking to enrol patients that are between 3 and 18 years old."
Is participation in this research study still available for those who qualify?
"Per clinicaltrials.gov, this research endeavor is still looking for participants. It was originally advertised on August 15th 2019 with the most recent amendment happening almost two years later on July 27th 2021."
Has the FDA given its stamp of approval for 129-Xe?
"There is a solid body of evidence confirming 129-Xe's safety, making it eligible for a score of 3."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What site did they apply to?
Share this study with friends
Copy Link
Messenger